New Insights into Medium-Chain Acyl-CoA Dehydrogenase Deficiency

Strategic Insights -

Researchers have made a breakthrough in understanding the molecular basis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency, a genetic disorder that affects fatty acid metabolism. Investigators at the Universitätsklinikum Hamburg-Eppendorf (UKE) in Hamburg, Germany, have developed a novel native gel colorimetric assay to quantify the activity of MCAD tetramers, allowing them to distinguish subtle differences in protein shape, enzymatic activity, and FAD content. This research has profound implications for understanding the impact of pathogenic variants on MCAD structure and function.

Key Takeaways:

  • Medium-chain specific acyl-CoA dehydrogenase (MCAD) is a mitochondrial homotetrameric flavoprotein that catalyzes the first step in fatty acid beta-oxidation.
  • MCAD deficiency arises from variants that either impair enzymatic activity or destabilize interactions between subunits, leading to protein aggregation.
  • The novel native gel colorimetric assay developed in this study allows for the quantification of MCAD tetramers separately from other protein forms.
  • The assay shows a linear correlation between protein amount and enzymatic activity for octanoyl-CoA, a physiological MCAD substrate.
  • Applying this method to clinically relevant MCAD variants allowed researchers to distinguish subtle differences in protein shape, enzymatic activity, and FAD content.
  • This research has implications for understanding the molecular basis of MCADD and may be extended to analyze variants in other acyl-CoA dehydrogenase family members.
  • The study was supported by the Universitätsklinikum Hamburg-Eppendorf (UKE) and the Centre for Structural Systems Biology (CSSB).

Statistics:

  • The study involved researchers from the Universitätsklinikum Hamburg-Eppendorf (UKE) in Hamburg, Germany.
  • The study was published in the journal Scientific Reports in 2025.
  • The research was supported by the Universitätsklinikum Hamburg-Eppendorf (UKE) and the Centre for Structural Systems Biology (CSSB).
  • The novel native gel colorimetric assay developed in this study allows for the quantification of MCAD tetramers separately from other protein forms.

Sources:

  • High-resolution native electrophoresis in-gel activity assay reveals biological insights of medium-chain fatty acyl-CoA dehydrogenase deficiency. Scientific Reports, 2025;15(1):37168.
  • NewsRx. New Oxidoreductases Acting on CH-CH Group Donors Findings from Alice Grun et al Outlined (High-resolution native electrophoresis in-gel activity assay reveals biological insights of medium-chain fatty acyl-CoA dehydrogenase deficiency). Life Science Weekly. November 4, 2025; p 3502.